Advertisement
Screener

Versant Venture Management, LLC Historic Quarter Change: USA Other Stocks, New

Versant Venture Management, LLC historic quarter change: USA Other Stocks, New

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 17 quarters from 2014-12-31 to 2026-06-30, Versant Venture Management, LLC opened 5 positions, added to 1, reduced 5 and sold out of 8.

  • Q2 2025: Stock Tempest Therapeutics, Inc.; Country of operation United States; Class Common Stock; Shares before 0.
  • Q4 2024: Stock Tempest Therapeutics, Inc.; Country of operation United States; Class Common Stock; Shares before 0.
  • Q1 2024: Stock Skye Bioscience, Inc.; Country of operation United States; Class Common Stock; Shares before 0.
  • Q3 2016: Stock Audentes Therapeutics, Inc.; Country of operation —; Class Common Stock; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1560009), 17 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-12); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-05); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-12); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-10); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-11); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-07); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-12); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-08); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-07); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-03); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-10-24); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-07-28); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-25); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-05-05); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-10-28); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-15); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-04-23). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2025Tempest Therapeutics, Inc.
CUSIP 87978U108
United StatesCommon Stock0269,772+269,772$0$1,834,450+$1,834,4502025-08-11
Q4 2024Tempest Therapeutics, Inc.
CUSIP 87978U108
United StatesCommon Stock03,507,055+3,507,055$0$2,926,637+$2,926,6372025-02-12
Q1 2024Skye Bioscience, Inc.
CUSIP 83086J200
United StatesCommon Stock02,007,702+2,007,702$0$31,400,459+$31,400,4592024-05-03
Q3 2016Audentes Therapeutics, Inc.
CUSIP 05070R104
Common Stock01,806,832+1,806,832$0$32,179,678,000+$32,179,678,0002016-10-24
Q3 2016Immune Design Corp.
CUSIP 45252L103
Common Stock02,208,210+2,208,210$0$16,738,232,000+$16,738,232,0002016-10-24

Similar Firms

Firm NameCountry13F ValueHoldings
Shum Financial Group, Inc.United States$0.141B93
Clearview Wealth Management LLCUnited States$0.141B60
Hummer Financial Advisory Services IncUnited States$0.141B129
Maytree Asset Management LtdHong Kong$0.141B20
TFJ Management, LLCUnited States$0.141B14
IF Advisors, LLCUnited States$0.141B53
Networth Advisors, LLCUnited States$0.141B381
PSP Research LLCUnited States$0.141B79
Renasant BankUnited States$0.141B240
Yorktown Energy Partners XI, L.P.United States$0.142B4